Abstract:2589 Background: Tumor mutation burden (TMB), calculated by whole-exome sequencing (WES) or large NGS panels, has an important association with immunotherapy responses. Elucidating the underlying biological mechanisms of high TMB might help develop more precise and effective means for TMB and immunotherapy response prediction. Meanwhile, the landscape of TMB across different cancer types and its association with other molecular features have not been well investigated in large cohorts in China. Methods: Cancer patients whose fresh tissue (n = 1556), formalin-fixed, paraffin-embed (FFPE) specimen (n = 1794), and pleural fluid (n = 84) were profiled using 295- or 520-gene NGS panel. The association of the TMB status with a series of molecular features and biological pathways was interrogated using bootstrapping. Results: TMB, measured by 295- or 520-cancer-related gene panels, were correlated with WES TMB based on in silico simulation in the TCGA cohort. We compared the TMB landscape across 11 cancer type groups and found the highest average TMB in lung squamous cell carcinoma, whereas the lowest TMB was established in sarcoma. High microsatellite instability, DNA damage response deficiency, and homologous recombination repair deficiency indicated significantly higher TMB. The independent predictive power for TMB of twenty-six biological pathways was tested in 10 cancer groups. FoxO signaling pathway most commonly correlated with low-TMB; significant association was identified in four cancer groups. In contrast, no pathway was significantly correlated with high-TMB in more than two cancer groups. Overall, we discovered that the underlying pathways which may be the main drivers of TMB status varied greatly and sometimes had an opposite association with TMB across different cancer types. Moreover, we developed a 14- and 22-gene signature for TMB prediction for LUAD and LUSC, respectively, with only 10 genes shared by both signatures, indicating a histology-specific mechanism for driving high-TMB in lung cancer. Conclusions: The findings extended the knowledge of the underlying biological mechanisms for high TMB and might be helpful for developing more precise and accessible TMB assessment panels and algorithms in more cancer types.

Data from Genetic Determinants of Somatic Selection of Mutational Processes in 3,566 Human Cancers

Genetic Determinants of Somatic Selection of Mutational Processes in 3,566 Human Cancers

Tumor Mutation Burden Analysis in a 5,660 Cancer Patient Cohort Reveals Cancer Type-Specific Mechanisms for High Mutation Burden.

Supplementary Data from Genetic Determinants of Somatic Selection of Mutational Processes in 3,566 Human Cancers

Table ST2 from Genetic Determinants of Somatic Selection of Mutational Processes in 3,566 Human Cancers

Table ST4 from Genetic Determinants of Somatic Selection of Mutational Processes in 3,566 Human Cancers

Table ST1 from Genetic Determinants of Somatic Selection of Mutational Processes in 3,566 Human Cancers

Mutational landscape and significance across 12 major cancer types

An Investigation of the Association of Genetic Susceptibility Risk with Somatic Mutation Burden in Breast Cancer

Signatures of mutational processes in human cancer

Unveiling the interplay between mutational signatures and tumor microenvironment: a pan-cancer analysis

Genome-wide Mutational Spectra Analysis Reveals Significant Cancer-Specific Heterogeneity

Mutation-Profile-Based Methods for Understanding Selection Forces in Cancer Somatic Mutations: A Comparative Analysis

Identifying Candidate Cancer Genes Based on Their Somatic Mutations Co-Occurring with Cancer Genes in Cancer Genome Profiling

Significant Prognostic Features and Patterns of Somatic TP53 Mutations in Human Cancers

Somatic Gene Mutation Signatures Predict Cancer Type and Prognosis in Multiple Cancers with Pan-Cancer 1000 Gene Panel.

A Comprehensive Catalogue of Somatic Mutations from a Human Cancer Genome

Table ST3 from Genetic Determinants of Somatic Selection of Mutational Processes in 3,566 Human Cancers

A Multiethnic Germline-Somatic Association Database Deciphers Multilayered and Interconnected Genetic Mutations in Cancer

Somatic Mutational Landscape Reveals Mutational Signatures and Significantly Mutated Genes of Cancer Immunotherapeutic Outcome and Sex Disparities

Mutational Processes Molding the Genomes of 21 Breast Cancers